Given evidence from patients and mouse models3, 6, 7 for a toxic dominant gain-of-function mechanism related to abnormal aggregation and toxicity of GFAP in Alexander disease, we have modelled the disorder by expressing disease-linked forms of human GFAP in fly glia8. The gene discussed is GFAP; the disease is Alexander disease.